Mustang Bio (MBIO) Insider Trading & Ownership $1.16 +0.04 (+3.57%) Closing price 05/19/2025 04:00 PM EasternExtended Trading$1.13 -0.03 (-2.59%) As of 08:14 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Mustang Bio (NASDAQ:MBIO) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage0.21%Number OfInsiders Buying(Last 3 Years)1Amount OfInsider Buying(Last 3 Years)$3,330.00Number OfInsiders Selling(Last 3 Years)0 Get MBIO Insider Trade Alerts Want to know when executives and insiders are buying or selling Mustang Bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address MBIO Insider Buying and Selling by Quarter Mustang Bio Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/18/2023Manuel Md LitchmanDirectorBuy6$555.00$3,330.00 (Data available from 1/1/2013 forward) MBIO Insider Trading Activity - Frequently Asked Questions Who is on Mustang Bio's Insider Roster? The list of insiders at Mustang Bio includes Manuel Md Litchman. Learn more on insiders at MBIO. What percentage of Mustang Bio stock is owned by insiders? 0.21% of Mustang Bio stock is owned by insiders. Learn more on MBIO's insider holdings. Mustang Bio Key ExecutivesMr. Michael S. Weiss Esq. (Age 58)Executive Chairman Compensation: $60kDr. Manuel Litchman M.D. (Age 70)President, CEO & Director Compensation: $480.79kMr. James B. Murphy (Age 67)Interim Chief Financial Officer Mr. Peter Carney (Age 37)Controller & Interim Chief Accounting Officer Mr. Matthew Wein J.D.VP & General CounselMs. Debra Manning SPHRSenior VP & Head of Human ResourcesMs. Lynn E. Bayless M.S.VP & Head of Regulatory AffairsDr. Bruce Dezube M.D.Senior VP & Head of Clinical DevelopmentMr. Greg Furrow M.S.Chief Quality OfficerMr. Richard Bodmer M.S.Head of CMC Development More Insider Trading Tools from MarketBeat Related Companies IN8bio Insider Transactions Flora Growth Insider Transactions BioCardia Insider Transactions GeoVax Labs Insider Transactions Equillium Insider Transactions Edesa Biotech Insider Transactions MEI Pharma Insider Transactions 23andMe Insider Transactions Relmada Therapeutics Insider Transactions Synlogic Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles UnitedHealth Insiders Double Down: Is UNH Stock a Value Play?Sprouts Stock: Insider Sales, But Strong Bullish Signals5 Hot Small-Cap Insiders Bought at the Peak of Tariff FearsThe Top-Ranked Insider Buys From April by Market CapMcDonald’s Insiders Sell Shares! Investors Should Do the Opposite This page (NASDAQ:MBIO) was last updated on 5/20/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredAI Firm Enters America's Largest Medicaid MarketNew York's $95B system just approved a new AI healthcare platform. Here's what to know. A major shift in U....i2i Marketing Group, LLC | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhy Is Elon Musk’s New Device Getting so Popular?Many folks who’ve used it are raving online, calling it…“A game-changer”... an “amazing product”... and “amazi...Brownstone Research | SponsoredLenin was right all along… It’s not often you hear praise for a Bolshevik from a veteran investor… but Porter Stansberry says Lenin got o...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mustang Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mustang Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MBIO Stock Free MBIO Stock Alerts